Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages 295-299

  Haraguchi, Kazutaka ^a,c   Hara, Shigeko ^a,b   Ubara, Yoshifumi ^a,b   Tanaka, Shoichiro ^c   Nukui, Ikuo ^a,c   Shimura, Hiroki ^c   Ohashi, Kenichi ^a,b   Kobayashi, Tetsuro ^c  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Diabetic nephropathy; Multifactorial treatment; Nephrotic syndrome; Proteinuria; Remission; Renal biopsy; Type 1 diabetes; VEGF

Indexed keywords

CILAZAPRIL; FUROSEMIDE; HEMOGLOBIN A1C; INSULIN; LOSARTAN; VASCULOTROPIN;

ADULT; ARTICLE; CASE REPORT; CREATININE CLEARANCE; CYSTIC FIBROSIS; DIABETIC NEPHROPATHY; DISEASE DURATION; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; PROTEIN RESTRICTION; PROTEINURIA; REMISSION; SODIUM RESTRICTION;

ADULT; ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; PROTEINURIA; REMISSION, SPONTANEOUS; RENAL CIRCULATION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 59349116156     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.10.019     Document Type: Article

References (12)

1. Fioretto P., Steffes M.W., Sutherland D.E., Goetz F.C., and Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Engl. J. Med. 339 (1998) 69-75
2. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
3. Hebert L.A., Bain R.P., Verme D., Cattran D., Whittier F.C., Tolchin N., et al. Remission of nephrotic range proteinuria in type 1 diabetes. Kidney Int. 46 (1994) 1688-1693
4. McGregor D., and Bailey R.R. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type 1 diabetics treated with an ACE inhibitor. Nephron 76 (1997) 270-275
5. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111 (2003) 707-716
6. Maharaj A.S., Saint-Geniez M., Maldonado A.E., and D'Amore P.A. Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 168 (2006) 639-648
7. Kitamoto Y., Tokunaga H., Miyamoto K., and Tomita K. VEGF is an essential molecule for glomerular structuring. Nephrol. Dial. Transplant. 17 Suppl. 9 (2002) 25-27
8. Gilbert R.E., and Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int. 56 (1999) 1627-1637
9. Fioretto P., Steffes M.W., and Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43 (1994) 1358-1364
10. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., and Krolewski A.S. Regression of microalbuminuria in type 1 diabetes. N. Engl. J. Med. 348 (2003) 2285-2293
11. Rezzani R. Cyclosporine A and adverse effects on organs: histochemical studies. Prog. Histochem. Cytochem. 39 (2004) 85-128
12. Hollander A.A., van Saase J.L., Kootte A.M., van Dorp W.T., van Bockel H.J., van Es L.A., et al. Beneficial effects of conversion from cyclosporine to azathioprine after kidney transplantation. Lancet 345 (1995) 610-614